Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
10/2013
10/03/2013US20130259901 Neuropeptide Y Treatment of Autoimmune Disease
10/03/2013US20130259889 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
10/02/2013EP2644697A1 Neuron-specific retrograde transport vector
10/02/2013EP2644600A1 Heterocyclic aspartyl protease inhibitors
10/02/2013EP2644198A1 Antianxiety and sleep disorder improving use of albiflorin or metabolite thereof in
10/02/2013EP2643325A1 Spiro-amino-imidazolone and spiro-amino-dihydro-pyrimidinone compounds as beta-secretase modulators and methods of use
10/02/2013EP2643320A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
10/02/2013EP2643303A1 Modulators of s1p receptors
10/02/2013EP2643299A1 Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions
10/02/2013EP2643297A1 Indole derivatives as modulators of s1p receptors
10/02/2013EP2643057A1 An implant for the controlled release of pharmaceutically active agents
10/02/2013EP2643056A2 Phagocytic activity as a marker of synucleinopathic disease
10/02/2013EP2642993A1 Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative
10/02/2013EP2642990A1 Therapeutic use of compounds
10/02/2013EP2642988A1 Method and composition for weight-gain management
10/02/2013EP2642985A1 Polymeric matrix of polymer-lipid nanoparticles as a pharmaceutical dosage form
10/02/2013EP2642859A2 Method of treating neurological conditions with extract of nerium species or thevetia species
10/02/2013CN103339144A Caspase-2 inhibitors
10/02/2013CN103339139A 7-deazapurine modulators of histone methyltransferase, and methods of use thereof
10/02/2013CN103339131A Pharmaceutical composition comprising pyridone derivatives
10/02/2013CN103339117A 1,4 oxazines as bace1 and/or bace2 inhibitors
10/02/2013CN103339109A Tetrahydroisoquinoline derivative
10/02/2013CN103339107A Novel azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
10/02/2013CN103338780A Composition for positively allosterically modulating GABAA-benzodiazepine receptor and composition for producing sedative-hypnotic effects containing ecklonia cava extract and ecklonia kurome extract
10/02/2013CN103338771A Patch preparation
10/02/2013CN103338761A Prophylactic or therapeutic drug for peripheral neuropathy caused by anticancer agent
10/02/2013CN103338759A 芳香化酶活化剂 Aromatase activator
10/02/2013CN103338752A Risperidone sustained release microsphere composition
10/02/2013CN103333919A Viruses AAVSTF for expressing iron nano particles and temperature-sensitive channel and application thereof
10/02/2013CN103333218A 3 alpha,11 alpha-dihydroxy-lupin-20(29)-alkene-28-acid with anti-inflammatory effect and preparation method thereof
10/02/2013CN103333216A 5alpha-6-ketone-cholestane analogue and applications thereof
10/02/2013CN103333163A Coumarone derivative, and preparation method and applications thereof
10/02/2013CN103333161A Preparation method and use of 1'-oxo-indirubin
10/02/2013CN103333156A Preparation method of 2-substituted arylethenyl-N-methylated quinoline derivative and application of 2-substituted arylethenyl-N-methylated quinoline derivative in preparation of drug for treating Alzheimer disease
10/02/2013CN103333141A Resveratrol oligomerization stilbene compound as well as preparation method and application thereof
10/02/2013CN103333107A Crystals of laquinimod sodium, and process for the manufacture thereof
10/02/2013CN103330946A 5 alpha- androstane-3 beta, 5,6 beta-triol injection and preparation method thereof
10/02/2013CN103330925A Drug for treating chorea minor and preparation method thereof
10/02/2013CN103330922A Chinese medicine composite for curing menstruation mental disorders caused by heart spirit confused by phlegm
10/02/2013CN103330912A Traditional Chinese medicament for treating insomnia
10/02/2013CN103330875A Medicine for curing rheumatism arthralgia
10/02/2013CN103330857A Pharmaceutical composition for treating peripheral facial paralysis
10/02/2013CN103330847A Chinese medicine formula for curing menstruation mental disorder caused by insufficiency of heart yin
10/02/2013CN103330841A Traditional Chinese medicine matched with lavipeditum for use
10/02/2013CN103330833A Traditional Chinese medicine for treating great occipital neuralgia
10/02/2013CN103330806A Drug for treatment of rheumatoid arthritis
10/02/2013CN103330799A Traditional Chinese medicine electuary for temperance
10/02/2013CN103330786A Medicinal composition for treating migraines, and preparation method thereof
10/02/2013CN103330785A Preparation method for medicament with functions of reinforcing qi and nourishing blood, and nourishing liver and kidney
10/02/2013CN103330769A Spray agent for treating epilepsy
10/02/2013CN103330748A Traditional Chinese medicine preparation used for treating facial paralysis and apoplexy sequela and preparation method of traditional Chinese medicine preparation
10/02/2013CN103330741A Japanese pagodatree twig injection
10/02/2013CN103330716A Preparation method of trivitamins B tablets
10/02/2013CN102813849B Preparation method of traditional Chinese medicine for treating dyspnea and tachypnea-type acute glomerulonephritis
10/02/2013CN102657836B Medicine composition used for treating insomnia
10/02/2013CN102641501B Application of NALP3-ASC inflammation complex and activator inhibitor thereof in terms of preparation of medicines for treating prion diseases
10/02/2013CN102631667B Nerve regeneration promotion injection and preparation method thereof
10/02/2013CN102511568B Fat adjusting hypnotic health care oil
10/02/2013CN102391305B Phosphate disodium salt hydrate of propofol hydroxyacid ester and preparation method and application thereof
10/02/2013CN102335204B Chinese medicine Jinshuibao pill preparation and preparation method thereof
10/02/2013CN102186489B Use of cinnamon bark extract for treating amyloid-associated diseases
10/01/2013US8546424 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
10/01/2013US8546403 Compounds that modulate intracellular calcium
10/01/2013US8546385 Benzoic pyrrolopyridine derivatives
10/01/2013US8546379 5HT2C receptor modulators
10/01/2013US8546377 Modulators of 5-HT receptors and methods of use thereof
10/01/2013US8546374 Amino-tetrazoles analogues and methods of use
10/01/2013US8546346 Methods to reprogram splice site selection in pre-messenger RNAs
10/01/2013US8546342 Composition for treating mental health disorders
10/01/2013US8546143 Compositions and methods for inhibiting expression of a target gene
10/01/2013US8545886 Extended release tablet formulations of flibanserin and method for manufacturing the same
10/01/2013US8545843 Treatment of vasculitis
10/01/2013US8545837 Methods and compositions for CNS delivery of iduronate-2-sulfatase
10/01/2013US8545833 Treatment of radiation injury using placental stem cells
10/01/2013US8545810 Methods and compositions for treatment of ADD/ADHD, depression, memory problems and other conditions
10/01/2013CA2681545C Fluorinated derivatives of deferiprone
10/01/2013CA2633374C Amine compound and use thereof for medical purposes
10/01/2013CA2632198C Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
10/01/2013CA2619010C Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/01/2013CA2615466C Benzofused five-membered heterocycles as inhibitors of catechol-o-methyltransferase (comt) enzyme
10/01/2013CA2612726C Halogenated pyrazolo [1,5-a]pyrimidines, processes, uses as gaba-a receptors ligand, compositions and intermediates
10/01/2013CA2611713C Treatment of sleep-wake disorders
10/01/2013CA2557845C Process for preparing, and composition and pharmaceutical dosage forms containing, an oxycodone salt having less than 25 ppm 14-hydroxycodeinone
10/01/2013CA2529613C Agent for repairing corneal sensitivity containing amide compound
10/01/2013CA2514510C Polymer conjugates of mutated neublastin
10/01/2013CA2467689C Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
10/01/2013CA2433862C Molecular antigen array presenting amyloid beta
10/01/2013CA2418531C Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects
09/2013
09/26/2013WO2013142490A2 Tauroursodeoxycholic acid attenuates or abolishes formation and deposition of amyloid-b peptide
09/26/2013WO2013142449A2 Treatment for chronic pain syndromes
09/26/2013WO2013142427A1 Compounds and methods for kinase modulation, and indications therefor
09/26/2013WO2013142346A1 Premature-termination-codons readthrough compounds
09/26/2013WO2013142307A1 Carbamate compounds and of making and using same
09/26/2013WO2013142266A1 Estrogen receptor modulators and uses thereof
09/26/2013WO2013142205A1 Pharmaceutical compositions comprising benzyl alcohol
09/26/2013WO2013142202A1 Pharmaceutical compositions comprising glycerol esters
09/26/2013WO2013142198A1 Pharmaaceutical compositions comprising fatty acid esters
09/26/2013WO2013141758A1 Pharmaceutical composition having neuroprotective, antiamnesic, antioxidant, antihypoxic, neurometabolic and anti-ischemic activity (variants)
09/26/2013WO2013141581A1 Pharmaceutical composition or health food comprising lonicera coerulea var. edulis fruit extracts as active ingredients for preventing or improving ischemic cerebrovascular diseases
09/26/2013WO2013140347A1 Sulphonamide derivatives of benzylamine for the treatment of cns diseases
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 1833